Modulation of AKT/GSK-3β signaling by ambrisentan alleviates chronic kidney disease

Pathology - Research and Practice 2026

View at publisher

Authors: Rohan Bhadange, Anil Bhanudas Gaikwad

DOI: 10.1016/j.prp.2026.156402

Cited by: 2

References: 55

Fields of Study & Subjects

Pulmonary Hypertension Research and Treatments Chronic Kidney Disease and Diabetes Nitric Oxide and Endothelin Effects

References 55